Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 17 citing articles:

Comprehensive Molecular Genetic Analysis in Glioma Patients by Next Generation Sequencing
T.-J. Kim, Ahwon Lee, Stephen Ahn, et al.
Brain Tumor Research and Treatment (2024) Vol. 12, Iss. 1, pp. 23-23
Open Access | Times Cited: 5
New Insights into Glioblastoma
Eugenia Cella, Alberto Bosio, Giuseppe Lombardi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4090-4090
Open Access | Times Cited: 4
Efficacy and safety of dabrafenib plus trametinib in pediatric versus adult gliomas: a systematic review and meta-analysis
Bardia Hajikarimloo, Salem M. Tos, Mohammadamin Sabbagh Alvani, et al.
Child s Nervous System (2025) Vol. 41, Iss. 1
Closed Access
Current status of precision oncology in adult glioblastoma
Johannes Weller, Anna‐Laura Potthoff, Thomas Zeyen, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 2
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology
Mark P. van Opijnen, Filip Y.F. de Vos, Edwin Cuppen, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Open Access | Times Cited: 2
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection – Update 1
Martin J. van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 2
The Original M2 And M6 Mouse Models Of Glioblastoma: Morphological And Molecular Characteristics Of Transplanted Tumor Tissue
V. V. Kudelkina, A. I. Alekseeva, A. S. Khalansky, et al.
(2024)
Open Access | Times Cited: 1
Durable benefit and slowdown in tumor growth dynamics with erdafitinib in a FGFR3-TACC3 fusion-positive IDH-wild type glioblastoma
Santiago Cabezas‐Camarero, Rebeca Pérez‐Alfayate, Carmen Polidura, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Actionable alterations in glioblastoma: insights from the implementation of genomic profiling as the standard of care from 2016 to 2023
Vincent Fougner, Thomas Urup, Hans Skovgaard Poulsen, et al.
Neuro-Oncology Practice (2024) Vol. 12, Iss. 1, pp. 34-44
Open Access | Times Cited: 1
Structural alterations of the EGFR gene in glioblastoma samples as a prognostic factor and molecular target for therapy
V. O. Varachev, Olga Yu. Susova, A. A. Мitrоfаnоv, et al.
Advances in molecular oncology (2024) Vol. 11, Iss. 3, pp. 68-78
Open Access | Times Cited: 1
Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers
V. O. Varachev, Olga Yu. Susova, A. A. Мitrоfаnоv, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13004-13004
Open Access | Times Cited: 1
Single-cell multi-omics analysis reveals candidate therapeutic drugs and key transcription factor specifically for the mesenchymal subtype of glioblastoma
Yufan Yang, Ziyuan Liu, Yerong Wei, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors
Julia C. Kuehn, Patrick Metzger, Nicolas Neidert, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma
Nayuta Higa, Toshiaki Akahane, Mari Kirishima, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155598-155598
Open Access
Dabrafenib plus trametinib in low-grade versus high-grade gliomas: a systematic review and meta-analysis
Bardia Hajikarimloo, Mohammad Amin Habibi, Alireza Kooshki, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion
Giulia Cerretti, Marta Padovan, Angela Guerriero, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives
Eugenia Cella, Alberto Bosio, Pasquale Persico, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102850-102850
Open Access
Page 1

Scroll to top